Quad Asset Management logo

Quad Asset Management

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Quad Asset Management is an Investment firm.

Investor Profile

Quad Asset Management has backed more than 8 startups, with 4 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Series B rounds (top funding stages).
  • Majority of deals are located in South Korea, United States.
  • Strong thematic focus on Biotechnology, Artificial Intelligence (AI), Medical.

Stage Focus

  • Series A (38%)
  • Series C (25%)
  • Series B (25%)
  • Series Unknown (13%)

Country Focus

  • South Korea (88%)
  • United States (13%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Medical
  • Software
  • Pharmaceutical
  • Machine Learning
  • Neuroscience
  • Biopharma
  • Robotics
  • Online Portals
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Quad Asset Management frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Kolon Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
DB Financial Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KB Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Solidus Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Mirae Asset Securities
North America, New York, United States, Nyack
Co-Investments: 1
Prophet Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Premier Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
K2 Investment Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2

Which angels does Quad Asset Management often collaborate with?

SK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Quad Asset Management?

Illimis Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Illimis Therapeutics is a science and technology company that develops treatment for degenerative brain and autoimmune diseases.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Series BJul 14, 2025
Amount Raised: $42,004,389
Prazer Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Prazer Therapeutics is a biotechnology company that generates novel therapeutics for refractory diseases.

BiotechnologyPharmaceuticalTherapeutics
Series BApr 1, 2025
Amount Raised: $19,728,977
Ubix Therapeutics

Seoul, Seoul-t'ukpyolsi, South Korea

Ubix Therapeutics is a research and development company that develops anti-cancer drugs.

BiotechnologyMedical
Series CDec 23, 2024
Amount Raised: $17,716,685
AIGEN Sciences

Seoul, Seoul-t'ukpyolsi, South Korea

AIGEN Sciences is an AI drug discovery platform that provides drug research and development services.

Artificial Intelligence (AI)BiotechnologyPharmaceuticalProduct Research
Series AOct 16, 2024
Amount Raised: $8,794,744
Cubixel

Seoul, Seoul-t'ukpyolsi, South Korea

Cubixel develops and commercializes optical inspection equipment for the medical and bio industry.

BiotechnologyMedical
Series UnknownSep 6, 2024
Amount Raised: $12,698,223
NEUROPHET

Gangneung, Kangwon-do, South Korea

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Series CNov 7, 2023
Amount Raised: $15,325,964
Creatz

Suwon, Ch'ungch'ong-namdo, South Korea

Creatz is a sports consulting online platform based on artificially generated data.

Artificial Intelligence (AI)Online PortalsSports
Series ADec 8, 2021
Amount Raised: $21,319,234
AKA

Santa Monica, California, United States

AKA is the invincible Generative AI company: to create revolutionary and life-saving AI product

Artificial Intelligence (AI)RoboticsSoftware
Series BJan 8, 2021
Amount Raised: $17,383,190
Rznomics

Gwangju, Kwangju-jikhalsi, South Korea

Rznomics is a biotechnology company.

BiopharmaBiotechnology
Series AOct 30, 2019
Amount Raised: $10,303,083

Find More Investors Like Quad Asset Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Quad Asset Management | Pipeseed